# The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"

> **NCT05299242** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 9 (actual)

## Conditions studied

- Frozen Shoulder

## Interventions

- **DRUG:** Adalimumab Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05299242
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-21
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-06-12
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-01-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05299242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05299242, "The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05299242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*